Search

Your search keyword '"Radich, J."' showing total 430 results

Search Constraints

Start Over You searched for: Author "Radich, J." Remove constraint Author: "Radich, J."
430 results on '"Radich, J."'

Search Results

1. European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

2. Elevated CO2 Enhances Otolith Growth in Young Fish (Supplementary Data)

13. Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia

16. Metalloenzymes

17. Metallothionein enzymes

31. PF405 DASCERN 2-YEAR EXTENDED FOLLOW-UP OF DASATINIB EFFICACY AND SAFETY IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WHO HAVE SUBOPTIMAL RESPONSES TO 3 MONTHS OF IMATINIB

35. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

36. Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

37. UNA BASSA ESPRESSIONE DELLA FOSFATASI SHP-1 CORRELA CON LA RESI-STENZA AL TRATTAMENTO CON INIBITORI DELLE TIROSIN KINASI IN PAZIENTIAFFETTI DA LEUCEMIA MIELOIDE CRONICA

38. Association between transporters genotype and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the tops trial

39. Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

41. Chronic myeloid leukemia: Reminiscences and dreams

42. Chronic myeloid leukemia: reminiscences and dreams

43. Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale

44. Sequential Treatment of Chronic Myeloid Leukemia Patients: A Decision-analytic Cost-effectiveness Study

45. Choosing a Tyrosine Kinase Inhibitor as First-line Therapy for Chronic Myeloid Leukemia under the Uncertainty of Long-term Effectiveness and Safety

46. Advances in the biology and therapy of chronic myeloid leukemia (CML): Proceedings from the 6(th) Post-ASH International CML and Myeloproliferative Neoplasms Workshop

48. Reduced Expression Level of SHP1 Gives An Additive Survival Advantage to the Ph plus Cells of Chronic Myeloid Leukemia (CML) Patients and Provides a Novel Pretreatment Predictor of Major Molecular Response Achievement in CML Patients

49. Elevated CO2 Enhances Otolith Growth in Young Fish (Supplementary Data)

Catalog

Books, media, physical & digital resources